新型三重免疫检测法检测A组链球菌抗体用于风湿热诊断的研发与评估
该研究将既往的流式微球检测法转移至Luminex平台,开发可同时定量ASO、ADB和SpnA抗体的三重检测法,并用超过350份血清(含97例急性风湿热患者)验证。结果显示ASO和ADB与现有方法高度相关,抗SpnA抗体在入院28天后显著下降(P<0.05),提示其可辅助判断近期A组链球菌感染。
要点
- 三重检测法可同时定量ASO、ADB和抗SpnA抗体,ASO和ADB与现有方法高度相关。
- 抗SpnA抗体在入院28天后显著下降(P<0.05),提示其衰减更快。
- 抗SpnA免疫动力学可支持近期A组链球菌感染的判断,辅助风湿热诊断分类。
核心结论
- 三重微球检测法可准确、可重复地定量ASO、ADB和抗SpnA抗体,ASO和ADB与现有方法高度相关。
- 抗SpnA抗体在入院28天后显著下降(P<0.05),提示其衰减更快,可支持近期A组链球菌感染的判断。
研究设计与样本
- 将既往流式微球检测法转移至Luminex平台,通过将链球菌溶血素O、DNaseB和SpnA偶联至光谱独特的磁珠,开发三重检测法。
- 使用超过350份受试者血清(包括97例急性风湿热患者)验证检测法并探索免疫动力学。
主要发现
- 操作参数显示三重检测法可产生准确且可重复的抗体滴度,ASO和ADB与现有检测方法高度相关。
- 按入院后天数分层,急性风湿热患者中<28天组与28+天组的ASO和ADB无差异。
- 抗SpnA在28+天组显著下降(P<0.05),提示其抗体衰减更快。
关键数值与推荐
- 抗SpnA在入院28+天组较<28天组显著下降(P<0.05)。
临床怎么用
- 抗SpnA免疫动力学可支持近期A组链球菌感染的判断,并可能辅助急性风湿热的诊断分类。
- 基于微球的检测法可实现链球菌血清学的高通量检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Streptococcal serology is a cornerstone in the diagnosis of acute rheumatic fever (ARF), a postinfectious sequela associated with group A Streptococcus infection. Current tests that measure anti-streptolysin O (ASO) and anti-DNaseB (ADB) titers require parallel processing, with their predictive value limited by the low rate of decay in antibody response. Accordingly, our objective was to develop and assess the diagnostic potential of a triplex bead-based assay, which simultaneously quantifies ASO and ADB together with titers for a third antigen, SpnA. Our previous cytometric bead assay was transferred to the clinically appropriate Luminex platform by coupling streptolysin O, DNaseB, and SpnA to spectrally unique magnetic beads. Sera from more than 350 subjects, including 97 ARF patients, were used to validate the assay and explore immunokinetics. Operating parameters demonstrate that the triplex assay produces accurate and reproducible antibody titers which, for ASO and ADB, are highly correlative with existing assay methodology. When ARF patients were stratified by time (days following hospital admission), there was no difference in ASO and ADB between <28 and 28+ day groups. However, for anti-SpnA, there was a significant decrease (P < 0.05) in the 28+ day group, indicative of faster anti-SpnA antibody decay. Anti-SpnA immunokinetics support very recent group A Streptococcus infection and may assist in diagnostic classification of ARF. Further, bead-based assays enable streptococcal serology to be performed efficiently in a high-throughput manner.
引用
- Whitcombe AL, Hanson-Manful P, Jack S, et al. Development and Evaluation of a New Triplex Immunoassay That Detects Group A Streptococcus Antibodies for the Diagnosis of Rheumatic Fever. J Clin Microbiol. 2020. PMID: 32461283. doi:10.1128/JCM.00300-20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。